Changing a leucine to a lysine residue makes NaeI endonuclease hypersensitive to DNA intercalative drugs.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochemistry

• Publication date

  1996-08-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI9604542PMID 8756463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topoisomerase Inhibitors

  2012cited by this paper
• Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (*)

  1995cited by this paper
• A Yeast Type II Topoisomerase Selected for Resistance to Quinolones

  1995cited by this paper
• Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA.

  1995cited by this paper
• Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin.

  1995cited by this paper
• A Mutation in Yeast TOP2 Homologous to a Quinolone-resistant Mutation in Bacteria

  1995cited by this paper
• DNA topoisomerase and recombinase activities in Nae I restriction endonuclease.

  1995cited by this paper
• Molecular interactions of DNA-topoisomerase I and II inhibitor with DNA and topoisomerases and in ternary complexes: binding modes and biological effects for intoplicine derivatives.

  1994cited by this paper
• DNA topoisomerases: essential enzymes and lethal targets.

  1994cited by this paper
• Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide.

  1994cited by this paper
• Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.

  1994cited by this paper
• Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors.

  1993cited by this paper
• On the simultaneous binding of eukaryotic DNA topoisomerase II to a pair of double-stranded DNA helices.

  1993cited by this paper
• Formation of a cleavasome: enhancer DNA-2 stabilizes an active conformation of NaeI dimer.

  1993cited by this paper
• Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D.

  1992cited by this paper
• Nonidentical DNA-binding sites of endonuclease NaeI recognize different families of sequences flanking the recognition site.

  1992cited by this paper
• NaeI endonuclease binding to pBR322 DNA induces looping.

  1991cited by this paper
• DNA gyrase: structure and function.

  1991cited by this paper
• Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

  1990cited by this paper
• Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases.

  1990cited by this paper
• Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers.

  1990cited by this paper
• DNA and spermidine provide a switch mechanism to regulate the activity of restriction enzyme Nae I.

  1989cited by this paper
• Unusual helical packing in crystals of DNA bearing a mutation hot spot

  1989cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• Inhibitors of DNA topoisomerases.

  1988cited by this paper
• The mechanism of conservative site-specific recombination.

  1988cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

  1984cited by this paper
• Ethidium binding sites on plasmid DNA determined by photoaffinity labeling.

  1984cited by this paper
• Cleavage of DNA by mammalian DNA topoisomerase II.

  1983cited by this paper
• DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties.

  1981cited by this paper
• The effect of several nucleic acid binding drugs on the cleavage of d(GGAATTCC) and pBR 322 by the Eco RI restriction endonuclease.

  1981cited by this paper
• Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

  1980cited by this paper
• DNA gyrase: subunit structure and ATPase activity of the purified enzyme.

  1978cited by this paper

• Metal‐Dependent Type II Restriction Endonucleases

  2006cites this paper
• Restriction Endonucleases: Structure of the Conserved Catalytic Core and the Role of Metal Ions in DNA Cleavage

  2004cites this paper
• Structure and Function of Type IIE Restriction Endonucleases — or: From a Plasmid That Restricts Phage Replication to A New Molecular DNA Recognition Mechanism

  2004cites this paper
• Amino Acid Substitutions at Position 43 of NaeI Endonuclease

  2003cites this paper
• Step-wise DNA relaxation and decatenation by NaeI-43K.

  1998cites this paper
• Cooperative Binding Properties of Restriction Endonuclease EcoRII with DNA Recognition Sites*

  1998cites this paper
• Effects on NaeI-DNA recognition of the leucine to lysine substitution that transforms restriction endonuclease NaeI to a topoisomerase: a model for restriction endonuclease evolution.

  1996cites this paper